Baudax Bio financials at a glance

+ Portfolio

The revenue of Baudax Bio is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -1.65 Dollars per share in 2023, which was 92.63 higher than 2020. And about -0.00132 billion Dollars are reported as free cash flow in the financials of Baudax Bio 2023. No dividends were paid to the shareholders of the Baudax Bio stock OTCPK:BXRX in the financial year 2023.

Forecast

Financials

Year	Year	TTM	2021	2020	2019	2018
Rev.	Revenue	N/A	$1.08M	$0.49M	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	-,126.39%	-,251.32%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-1.91	$-,405.60	$-5,502.01	$-4,872.00	$-12,600.01
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0
Sha.	Shares	N/AM	0.16M	0.05M	0.01M	0M
OCF	Operating Cash Flow	N/A	$-49.27M	$-44.06M	$-50.04M	$0.00M
FCF	Free Cash Flow	N/A	$-49.47M	$-44.70M	$-51.36M	$0.00M
FCFS	Free Cash Flow Per Share	$-3.60	$-22.60	$-83.92	$-,192.87	$0.00

Baudax Bio financials at a glance

Financials

Discover